Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
177Lu-NI-FAPI in Fibroblast Activation Related Tumors
NCT07822347Phase 2Enrolling by invitation
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of 177Lu-NI-FAPI in tumor, sponsored by Peking Union Medical College Hospital. Started Aug 2025; status: enrolling by invitation.
02
Drugs
177Lu-NI-FAPI
03
Conditions
tumor
Beyond the preview
Go deeper on NCT07822347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07822347.